Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04994509
PHASE3

Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection

Sponsor: Gilead Sciences

View on ClinicalTrials.gov

Summary

The goal of this study is to evaluate the efficacy of the study drugs, lenacapavir (LEN) and emtricitabine/tenofovir alafenamide (F/TAF) in preventing HIV infection, in adolescent girls and young women (AGYW). The primary objective of this study is to evaluate the efficacy of LEN and F/TAF for HIV-1 PrEP in AGYW at risk of HIV-1 infection.

Official title: A Phase 3, Double-Blinded, Multicenter, Randomized Study to Evaluate Safety and Efficacy of Twice Yearly Long-Acting Subcutaneous Lenacapavir, and Daily Oral Emtricitabine/Tenofovir Alafenamide for Pre-Exposure Prophylaxis in Adolescent Girls and Young Women at Risk of HIV Infection

Key Details

Gender

FEMALE

Age Range

16 Years - 25 Years

Study Type

INTERVENTIONAL

Enrollment

5368

Start Date

2021-08-30

Completion Date

2028-01

Last Updated

2026-03-30

Healthy Volunteers

Yes

Interventions

DRUG

Oral Lenacapavir (LEN)

Tablets administered orally without regard to food

DRUG

Subcutaneous (SC) Lenacapavir (LEN)

Administered via SC injections

DRUG

F/TAF

Tablets administered orally

DRUG

F/TDF

Tablets administered orally

DRUG

Placebo SC LEN

Administered via SC injections

DRUG

PTM Oral LEN

Tablets administered orally

DRUG

PTM F/TAF

Tablets administered orally

DRUG

PTM F/TDF

Tablets administered orally

Locations (28)

Madibeng Centre for Research

Brits, South Africa

Emavundleni Research Centre

Cape Town, South Africa

Vuka Research Clinic

Cape Town, South Africa

Desmond Tutu Health Foundation Clinical Trials Unit

Cape Town, South Africa

Botha's Hill Clinical Research Site, HIV Prevention Research Unit

Durban, South Africa

CAPRISA eThekwini Clinical Research Site

Durban, South Africa

CAPRISA Vulindlela Clinical Research Site

Durban, South Africa

MatCH Research Unit, Suite 1112, 11th Floor

Durban, South Africa

Synergy Biomed Research Institute (SBRI)

East London, South Africa

Setshaba Research Centre

Gauteng, South Africa

Wits Reproductive Health & HIV Institute (Wits RHI)

Johannesburg, South Africa

The Aurum Institute: Gavin J Churchyard Legacy Centre, Klerksdorp Clinical Research Centre

Klerksdorp, South Africa

Perinatal HIV Research Unit (PHRU) Soweto Kliptown

Kliptown, South Africa

Phoenix Clinical Research Site, South African Medical Research Council, HIV and Other Infectious Disease Research Unit

Kwa Zulu Natal, South Africa

Verulam Clinical Research Site, South African Medical Research Council, HIV and Other Infectious Disease Research Unit

Kwa Zulu Natal, South Africa

Tongaat Clinical Research Site, South African Medical Research Council, HIV and Other Infectious Disease Research Unit

Kwa Zulu Natal, South Africa

Chatsworth Clinical Research Site, South African Medical Research Council, HIV and Other Infectious Disease Research Unit

Kwa Zulu Natal, South Africa

Qhakaza Mbokodo Research Clinic

Ladysmith, South Africa

Africa Health Research Institute

Mtubatuba, South Africa

The Aurum Institute: Pretoria Clinical Research Centre

Pretoria, South Africa

The Aurum Institute: Rustenburg Clinical Research Centre

Rustenburg, South Africa

Desmond Tutu Health Foundation - Masiphumelele Research Office

Sunnydale, South Africa

The Aurum Institute: Tembisa Clinical Research Centre

Tembisa, South Africa

CAPRISA Umlazi Clinical Research Site

Umlazi, South Africa

FPD-DTHF Ndevana Community Research Site

Vincent, South Africa

Makerere-Kalangala Clinical Research site

Kalangala, Uganda

AMBSO Masaka Clinical Research site

Kyotera- Masaka Region, Uganda

Makerere University- John Hopkins University (MU-JHU) Mityana Research Site (MU-JHU) Care Ltd

Mityana Town, Uganda